Analysis of risk factors for systemic inflammatory response syndrome in patients after transcatheter aortic valve replacement

被引:0
作者
Cheng, Jifang [1 ,2 ]
Dong, Mingqi [1 ]
Wen, Chunjie [1 ]
Yu, Bin [1 ]
Fan, Jiaqi [1 ]
机构
[1] Univ Sch Med, Affiliated Hosp Zhejiang 2, Hangzhou, Peoples R China
[2] Univ Sch Med, Affiliated Hosp Zhejiang 2, Hangzhou 310003, Peoples R China
关键词
Transcatheter aortic valve replacement; Systemic inflammatory response syndrome; Risk factors; Age; Body mass index; IMPACT;
D O I
10.1007/s00059-023-05163-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveOur aim was to determine the risk factors of postoperative systemic inflammatory response syndrome (SIRS) in patients with transcatheter aortic valve replacement (TAVR), identify those with a high risk of SIRS, and help reduce SIRS occurrence.MethodsA retrospective cohort study was conducted to collect the clinical data of patients who underwent TAVR from January 2014 to December 2019 at a tertiary hospital in Zhejiang Province. The study included 156 men and 94 women. Patients were divided into SIRS and non-SIRS groups. The pre-, intra-, and postoperative indices of the two groups were recorded. The data of the two groups were compared, and univariate analysis was performed. All statistically significant factors were assessed using binary logistic regression analysis to clarify the risk factors of SIRS after TAVR.ResultsOverall, 30 patients developed SIRS after TAVR, with an incidence rate of 12%, an odds ratio (OR) of 0.571, and a 95% confidence interval (CI) of 0.469-0.694 (p = 0.000). There was a significant correlation between SIRS and glucose (OR: 0.823, 95% CI: 0.678-1.000, p = 0.049), albumin (OR: 0.938, 95% CI: 0.881-0.998, p = 0.044), brain natriuretic peptide (OR: 1.000, 95% CI: 1.000-1.000, p = 0.010), sex (OR: 0.412, 95% CI: 0.190-0.892, p = 0.025), and history of hypertension (OR: 0.375, 95% CI: 0.169-0.819, p = 0.014). Multivariate regression analysis demonstrated that age (OR: 1.190, 95%CI: 1.073-1.319, p = 0.001) and body mass index (BMI; OR: 0.559, 95% CI: 0.447-0.698, p = 0.000) were independent risk factors for postoperative SIRS in patients with TAVR.ConclusionThe incidence of SIRS after TAVR was 12%. There was a significant correlation between SIRS and albumin, glucose, and hypertension. The independent risk factors for SIRS after TAVR were age and BMI.
引用
收藏
页码:393 / 398
页数:6
相关论文
共 21 条
  • [11] Informed Shared Decisions for Patients with Aortic Stenosis
    Otto, Catherine M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18) : 1769 - 1770
  • [12] Rettig Thijs C D, 2018, J Cardiothorac Vasc Anesth, V32, pe77, DOI 10.1053/j.jvca.2017.12.051
  • [13] The Systemic Inflammatory Response Syndrome Predicts Short-Term Outcome After Transapical Transcatheter Aortic Valve Implantation
    Rettig, Thijs C. D.
    Rigter, Sander
    Nijenhuis, Vincent J.
    van Kuijk, Jan-Peter
    ten Berg, Jurrien M.
    Heijmen, Robin H.
    van de Garde, Ewoudt M. W.
    Noordzij, Peter G.
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2015, 29 (02) : 283 - 287
  • [14] Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves
    Schwietz, Thomas
    Behjati, Sohil
    Gafoor, Sameer
    Seeger, Florian
    Doss, Mirko
    Sievert, Horst
    Zeiher, Andreas M.
    Fichtlscherer, Stephan
    Lehmann, Ralf
    [J]. EUROINTERVENTION, 2015, 10 (12) : 1468 - 1473
  • [15] Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation
    Sinning, Jan-Malte
    Scheer, Anne-Catherine
    Adenauer, Viktoria
    Ghanem, Alexander
    Hammerstingl, Christoph
    Schueler, Robert
    Mueller, Cornelius
    Vasa-Nicotera, Mariuca
    Grube, Eberhard
    Nickenig, Georg
    Werner, Nikos
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (12) : 1459 - 1468
  • [16] Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis
    Siontis, George C. M.
    Overtchouk, Pavel
    Cahill, Thomas J.
    Modine, Thomas
    Prendergast, Bernard
    Praz, Fabien
    Pilgrim, Thomas
    Petrinic, Tatjana
    Nikolakopoulou, Adriani
    Salanti, Georgia
    Sondergaard, Lars
    Verma, Subodh
    Juni, Peter
    Windecker, Stephan
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (38) : 3143 - 3153
  • [17] Incidence, Causes, and Impact of In-Hospital Infections After Transcatheter Aortic Valve Implantation
    Tirado-Conte, Gabriela
    Freitas-Ferraz, Afonso B.
    Nombela-Franco, Luis
    Jimenez-Quevedo, Pilar
    Biagioni, Corina
    Cuadrado, Ana
    Nunez-Gil, Ivan
    Salinas, Pablo
    Gonzalo, Nieves
    Ferrera, Carlos
    Vivas, David
    Higueras, Javier
    Viana-Tejedor, Ana
    Jose Perez-Vizcayno, Maria
    Vilacosta, Isidre
    Escaned, Javier
    Fernandez-Ortiz, Antonio
    Macaya, Carlos
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (03) : 403 - 409
  • [18] 2021 ESC/EACTS Guidelines for the management of valvular heart disease
    Vahanian, Alec
    Beyersdorf, Friedhelm
    Praz, Fabien
    Milojevic, Milan
    Baldus, Stephan
    Bauersachs, Johann
    Capodanno, Davide
    Conradi, Lenard
    De Bonis, Michele
    De Paulis, Ruggero
    Delgado, Victoria
    Freemantle, Nick
    Gilard, Martine
    Haugaa, Kristina H.
    Jeppsson, Anders
    Juni, Peter
    Pierard, Luc
    Prendergast, Bernard D.
    Sadaba, J. Rafael
    Tribouilloy, Christophe
    Wojakowski, Wojtek
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (04) : 727 - 800
  • [19] Temporary Trends in Fever following Transcatheter Aortic Valve Implantation
    Witberg, Guy
    Kornowski, Ran
    Vaknin-Assa, Hana
    Codner, Pablo
    Bental, Tamir
    Yahav, Dafna
    Goldberg, Elad
    Perl, Leor
    Schwartzenberg, Shmuel
    Sagie, Alex
    Orvin, Katia
    [J]. CARDIOLOGY, 2021, 146 (03) : 359 - 367
  • [20] Xiang J., 2021, J CLIN CARDIOL, V37, P468